Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1996 | 06-1996 | 03-1996 | 12-1995 | 09-1995 | |
| Sales | 2,940 | 7,630 | 7,480 | 6,610 | 14,220 |
| Cost of Goods | 4,790 | 5,520 | 4,560 | 8,610 | 12,070 |
| Gross Profit | -1,850 | 2,110 | 2,920 | -2,000 | 2,150 |
| Operating Expenses | 0 | 0 | 0 | 650 | 0 |
| Operating Income | -1,850 | 2,110 | 2,920 | -2,650 | 2,150 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | -2,520 | -2,101 | -1,870 | -1,530 | -2,110 |
| Pre-tax Income | -4,370 | 9 | 1,050 | -4,180 | 20 |
| Income Tax | 0 | 0 | 0 | -1,530 | 0 |
| Net Income Continuous | -4,370 | 9 | 1,050 | -2,650 | 20 |
| Net Income | $-3,590 | $7 | $840 | $-3,130 | $10 |
| EBITDA(a) | $-1,850 | $2,110 | $2,920 | $-2,650 | $2,150 |